Results 171 to 180 of about 166,918 (340)
Genomic and Immune Correlates of EZH2 Expression and Activity in Olfactory Neuroblastoma
ABSTRACT Purpose Olfactory neuroblastoma (ONB) is a rare sinonasal malignancy with limited therapeutic options in the recurrent/metastatic setting; little is known regarding its responsiveness to immunotherapy. Inhibition of enhancer of zeste homolog 2 (EZH2) has been shown to improve T‐cell‐mediated killing and susceptibility to immune checkpoint ...
Elisabetta Xue +12 more
wiley +1 more source
Objective: Neuroendocrine neoplasms of primary breast tumors are rare compared to locations, such as the respiratory system and gastrointestinal system, where they are frequently observed.
Mine Ozsen +4 more
doaj +1 more source
Quality of Life After Surgical Treatment of Head and Neck Paragangliomas
ABSTRACT Background Head and neck paragangliomas (HNPGLs) are rare neuroendocrine tumors and often arise in the head and neck. Due to their localization, the tumor and its surgical treatment pose a risk for cranial nerve impairments. Few studies have focused on the health‐related quality of life (HRQOL) in patients with HNPGLs and their relation to ...
Christina Sauter +5 more
wiley +1 more source
Background Previous observational studies have hinted at a connection between the gut microbiota and pituitary neuroendocrine tumors, yet the causal nature of this relationship remains uncertain.
Wencai Wang +4 more
doaj +1 more source
Molecular imprinting for neurology: Materials, applications, and limitations
Molecularly imprinted materials: diagnostic, therapeutic and research applications in neurology. Molecularly imprinted materials offer high specificity and affinity for target molecules in neurological applications. This review highlights their synthesis, characterisation, and use in diagnostics, research and therapeutics.
Xiaohan Ma +3 more
wiley +1 more source
Endoscopic treatment and management of rectal neuroendocrine tumors less than 10 mm in diameter
Xiaoxin Ma +4 more
openalex +1 more source
What's New? Mismatch repair deficiency (dMMR) in rectal cancer is rare, and knowledge about tumor biological behavior, response to treatment, and clinical outcomes in this subset of patients is limited. This nationwide cohort study including 182 patients with dMMR rectal cancer found that they were younger and had more poorly differentiated tumors ...
Renee A. Lunenberg +14 more
wiley +1 more source
Clinical and pathological profile of gastric neuroendocrine tumors
Kim Vaiphei, Aravind Sekar
openalex +1 more source

